SLC5A2 and diabetic ketoacidosis: One of the seven patients was admitted with euglycemic diabetic ketoacidosis (venous blood gas of 7.26, bicarbonate of 13, anion gap of 21, and ketonuria) while being treated with an SGLT2 inhibitor (empagliflozin 10 mg daily) as well as metformin (1000 mg twice daily).